Display Settings:

Format

Send to:

Choose Destination

    Bioorg Med Chem. 2008 Jan 15;16(2):874-80. Epub 2007 Oct 22.

    Design, synthesis and structure-activity study of shorter hexa peptide analogues as HIV-1 protease inhibitors.

    Narendra Babu SN, Rangappa KS.

    Department of Studies in Chemistry, University of Mysore, Manasagangotri, Mysore 570006, Karnataka, India.

    Inhibition of HIV-1 protease enzyme can render the Human Immunodeficiency Virus (HIV-1) non-infectious in vitro. Previous studies have shown that several shorter peptides were discovered as HIV-1 protease inhibitors. In this context, a series of shorter synthetic hexapeptides, Leu-Leu-Glu-Tyr-Val-Xaa (Xaa=Phe, Met, Tyr and Trp), were designed. The synthesized hexa peptides were screened for their HIV-1 protease inhibition. These peptides showed moderately good HIV-1 protease inhibition when compared to acetyl pepstatin.

    PMID: 17981043 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read